Europe allows exemption for medical CFCs :
This article was originally published in Clinica
Continued exemptions for some medical applications are included in updated European legislation on ozone-depleting substances which has cleared its final stages in the European Parliament. A new regulation will allow national governments to permit the use of CFCs until December 31 2004 "in delivery mechanisms for hermetically sealed devices designed for implantation in the human body for delivery of measured doses of medication". The regulation will replace existing EU legislation on Europe's implementation of the Vienna convention for the protection of the ozone layer and the Montreal protocol on substances that deplete the ozone layer. The current 1994 regulation will be replaced by the new text on October 1. The regulation is directly binding and applies in all member states.
You may also be interested in...
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.